GLOBAL CONTRACEPTIVE COMMODITY GAP ANALYSIS
The global family planning community is on the cusp of a crisis: a widening funding gap threatens to interrupt access to contraceptive supplies for millions of women, and donor funding for supplies is increasingly precarious.
RHSC’s Contraceptive Commodity Gap Analysis (CGA) contributes vital data and analysis to inform strategies to close the gap and secure future supply availability.
The Commodity Gap Analysis (CGA 2019) is the fifth in a series dating back to 2001. This edition draws on a wider range of data sources than ever before; and for the first time makes use of an innovative interactive format that allows readers to assemble and analyze data in ways that meet their own needs. The CGA 2019 offers a more nuanced understanding of the current and future landscape of supplies funding by providing a more nuanced picture of the role of subsidy within the private sector, projecting findings forward to 2030, and, segmenting results to highlight fundamental differences in patterns of spending, use, and costs by country income level.
Donor expenditures on commodity procurement have declined in recent years and will likely continue to decline or, at best, remain stagnant in the coming decade. It is therefore crucial to understand the relative role of donor support across countries, and what will be required to ensure that remaining support is targeted wisely to address the needs of women in those countries that need it most.
The public and private sectors play equally important roles in the contraceptive supplies market, but they are by no means interchangeable. The public sector primarily provides long-acting and permanent methods (LAPMs); indeed, two-thirds (67%) of public sector users rely on LAPMs.